Correlation analysis confirms differences in antioxidant defence in the blood of types I and II schizophrenic male patients treated with anti-psychotic medication
Authors:Miljević, Cedo D
Lecić-Tosevski, Dusica M
Jones, David R
Article (Published version)
MetadataShow full item record
The activities of antioxidant defence enzymes were determined in erythrocytes isolated from types I and II schizophrenic male patients and from healthy controls. Significant differences in superoxide dismutase (SOD) activity (type I: 3284 +/- 577; type II: 2959 +/- 697 compared with controls: 3778 +/- 577; analysis of variance (ANOVA) P<0.001), catalase (CAT) activity (type I: 17.8 +/- 1.8 compared to type II: 19.2 +/- 1.5 and both compared with controls: 19.2 +/- 1.5; ANOVA P<0.05). glutathione peroxidase (GSH-Px) activity (controls: 17.8 +/- 2.3; type I: 13.9 +/- 2.9 and type II: 11.6 +/- 1.9; ANOVA P<0.001) as well as in glutathione reductase (GR) activity (controls: 5.0 +/- 0.8; type I: 4.3 +/- 0.9 and type II: 4.5 +/- 0.8; ANOVA P<0.01) were apparent. Correlation analysis of antioxidant defence enzymes showed significant negative correlation between GSH-Px and CAT activities (P<0.01) in type I patients. In type II patients, GSH-Px activity was significantly positively correlated with GR (P<0.01). Canonical discriminant analysis separated type I and type II patients from controls (and among each other) with a high degree of certainty according to the overall group composition of antioxidant defence enzymes. Our results indicate differences in the composition of antioxidant defence between controls and antipsychotic treated type I and type II patients with a possible negative feedback influence on the pathological process, which could provide a rationale for applying antioxidants during schizophrenic therapy. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
Source:Psychiatry Research, 2010, 178, 1, -72